// App-Quantinova.ai

P1-18-11 : Cardiac events in patients with HER2-positive metastatic breast cancer who have low left ventricular ejection fraction prior to initiating treatment with ado-trastuzumab emtansine: A retrospective cohort study using electronic health record data

Researchers

Presenter

  • Thibaut Sanglier

Principal Investigators

  • Jinjoo Shim

  • Harry Liu

  • Chunyan Song

  • Melanie Smitt

  • Evelyn M Flahavan

Medical Centers

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Genentech, Inc., South San Francisico, CA

  • Roche Products Ltd., Welwyn Garden City, United Kingdom

Locations

  • Switzerland

  • United States

  • United Kingdom

Companies

  • F. Hoffmann-La Roche

  • Genentech, Inc.

  • Feng Chi Biotech Cor

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Trastuzumab emtansine

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved